Atria Wealth Solutions Inc. Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atria Wealth Solutions Inc. cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 41.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,891 shares of the medical equipment provider's stock after selling 6,304 shares during the period. Atria Wealth Solutions Inc.'s holdings in Intuitive Surgical were worth $4,641,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. State Street Corp grew its stake in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. FMR LLC boosted its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC boosted its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after buying an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. raised its stake in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after acquiring an additional 24,183 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,348 shares of company stock valued at $3,587,582. Insiders own 0.90% of the company's stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $14.78 during trading on Friday, hitting $591.79. 1,673,828 shares of the company's stock traded hands, compared to its average volume of 1,567,754. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $210.78 billion, a P/E ratio of 92.32, a PEG ratio of 5.85 and a beta of 1.39. The business has a 50-day simple moving average of $565.45 and a 200-day simple moving average of $525.06.

Wall Street Analyst Weigh In

Several equities research analysts have commented on ISRG shares. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Evercore ISI increased their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Citigroup increased their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.